The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
23352510 |
37 |
Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.![EBI](/images/logo_chembl.png) |
Roche Palo Alto |
20138512 |
82 |
Discovery of potent and bioavailable GSK-3beta inhibitors.![EBI](/images/logo_chembl.png) |
Roche Palo Alto |
18183025 |
12060 |
A quantitative analysis of kinase inhibitor selectivity.![EBI](/images/logo_chembl.png) |
Ambit Biosciences |
22037378 |
31824 |
Comprehensive analysis of kinase inhibitor selectivity.![EBI](/images/logo_chembl.png) |
Ambit Biosciences |
19654408 |
2521 |
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).![EBI](/images/logo_chembl.png) |
Ambit Biosciences |
31381325 |
46 |
Discovery of Inhibitors of Aurora/PLK Targets as Anticancer Agents.![EBI](/images/logo_chembl.png) |
Chengdu University |
22404847 |
24 |
Synthesis and Biological Evaluation of N-aryl-4-aryl-1,3-Thiazole-2-Amine Derivatives as Direct 5-Lipoxygenase Inhibitors.![BDB](/images/logo_bindingdb.png) |
Korea Research Institute of Chemical Technology |